tiprankstipranks
NeoGenomics (NEO)
NASDAQ:NEO

NeoGenomics (NEO) Financial Statements

1,742 Followers

NeoGenomics Financial Overview

NeoGenomics's market cap is currently ―. The company's EPS TTM is $-0.669; its P/E ratio is -21.66; NeoGenomics is scheduled to report earnings on July 29, 2024, and the estimated EPS forecast is
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 156.24M$ 155.55M$ 151.95M$ 146.92M-
Gross Profit$ 65.47M$ 67.59M$ 62.31M$ 59.89M$ -82.41M
EBIT$ -26.00M$ -1.55M$ -24.29M$ -29.16M$ -35.19M
EBITDA$ -7.00M$ 17.54M$ -5.44M$ -10.19M$ -16.64M
Net Income Common Stockholders$ -27.06M$ -14.33M$ -18.52M$ -24.33M$ -30.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 384.83M$ 415.20M$ 402.26M$ 409.35M$ 275.61M
Total Assets$ 1.64B$ 1.68B$ 1.68B$ 1.70B$ 1.71B
Total Debt$ 608.18M$ 611.68M$ 605.70M$ 609.59M$ 752.63M
Net Debt$ 223.35M$ 196.48M$ 203.44M$ 200.24M$ 477.02M
Total Liabilities$ 716.93M$ 739.69M$ 730.81M$ 738.92M$ 734.71M
Stockholders Equity$ 923.41M$ 941.54M$ 947.43M$ 956.19M$ 974.46M
Cash Flow-
Free Cash Flow$ -31.50M$ 10.73M$ -9.77M$ -9.04M$ -22.62M
Operating Cash Flow$ -25.91M$ 17.78M$ -5.50M$ -1.55M$ -12.69M
Investing Cash Flow$ 14.53M$ 17.20M$ 20.82M$ 14.95M$ 23.74M
Financing Cash Flow$ 816.00K$ 1.27M$ 1.84M$ 64.00K$ 1.38M
Currency in USD

NeoGenomics Earnings and Revenue History

NeoGenomics Debt to Assets

NeoGenomics Cash Flow

NeoGenomics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis